Medicine Man Oy is a limited company based in Helsinki, registered in 1997. In the financial year ending 31.8.2025, revenue was 338 t€ and operating profit 50 t€; equity ratio 86.8 %. Its taxable income in 2024 was 109 t€ and its income taxes 22 t€. Public buyers bought 7 000 € from it in 2023–2026; the largest buyer is Kaupunginkanslia, Helsinki (Helsinki).
Financials
| Key figures | 31.8.2025 | 31.8.2024 | 31.8.2023 | 31.8.2022 |
|---|---|---|---|---|
| Revenue | 338 t€ | 297 t€ | 297 t€ | 301 t€ |
| Revenue change | 13,9 % | -0,1 % | -1,3 % | – |
| EBITDA | 49 t€ | 103 t€ | 125 t€ | 148 t€ |
| EBITDA % | 14,5 % | 34,8 % | 42,1 % | 49,3 % |
| Operating profit | 50 t€ | 103 t€ | 125 t€ | 148 t€ |
| Operating margin | 14,6 % | 34,7 % | 42,0 % | 49,1 % |
| Net profit | 43 t€ | 85 t€ | 99 t€ | 109 t€ |
| Personnel costs | -144 t€ | 56 t€ | 50 t€ | 68 t€ |
| Equity ratio | 86,8 % | 93,2 % | 91,6 % | 91,2 % |
| Quick ratio | 5,60 | 19,63 | 11,90 | 14,83 |
| Current ratio | 5,60 | 19,63 | 11,90 | 14,83 |
| Debt to revenue | 41,4 % | 23,3 % | 29,3 % | 29,3 % |
| Return on equity | 4,7 % | 8,9 % | 10,5 % | 11,9 % |
| Balance sheet total | 1,1 M€ | 1,0 M€ | 1,0 M€ | 1,0 M€ |
| Equity | 921 t€ | 954 t€ | 945 t€ | 919 t€ |
| Cash and bank | 133 t€ | 128 t€ | 78 t€ | 159 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.8.2025 | 31.8.2024 | 31.8.2023 | 31.8.2022 | |
|---|---|---|---|---|
| Turnover | 338 t€ | 297 t€ | 297 t€ | 301 t€ |
| Other operating income | 19 t€ | 20 t€ | 14 t€ | 38 t€ |
| Raw materials and services | 37 t€ | -40 t€ | -37 t€ | -26 t€ |
| Personnel expenses | 144 t€ | -56 t€ | -50 t€ | -68 t€ |
| Depreciations and reductions in value | 317 € | -423 € | -564 € | -752 € |
| Other operating expenses | 127 t€ | -118 t€ | -99 t€ | -97 t€ |
| Operating profit (loss) | 50 t€ | 103 t€ | 125 t€ | 148 t€ |
| Financial income and expenses + (-) | -4 752 € | 4 334 € | 590 € | -6 413 € |
| Profit (loss) before appropriations and taxes | 54 t€ | 107 t€ | 125 t€ | 141 t€ |
| Income taxes | 11 t€ | -22 t€ | -26 t€ | -32 t€ |
| Profit (loss) for the financial year | 43 t€ | 85 t€ | 99 t€ | 109 t€ |
Balance sheet
| 31.8.2025 | 31.8.2024 | 31.8.2023 | 31.8.2022 | |
|---|---|---|---|---|
| Non-current assets | 448 t€ | 448 t€ | 584 t€ | 572 t€ |
| Receivables | 85 t€ | 69 t€ | 33 t€ | 39 t€ |
| Cash in hand and at banks | 133 t€ | 128 t€ | 78 t€ | 159 t€ |
| Current assets | 612 t€ | 575 t€ | 447 t€ | 435 t€ |
| Assets | 1,1 M€ | 1,0 M€ | 1,0 M€ | 1,0 M€ |
| Share capital or other similar capital | 2 523 € | 2 523 € | 2 523 € | 2 523 € |
| Capital and reserves | 921 t€ | 954 t€ | 945 t€ | 919 t€ |
| Long-term liabilities | 30 t€ | 40 t€ | 49 t€ | 59 t€ |
| Short-term liabilities | 109 t€ | 29 t€ | 38 t€ | 29 t€ |
| Liabilities | 140 t€ | 69 t€ | 87 t€ | 88 t€ |
All financial statement items (52)
| 31.8.2025 | 31.8.2024 | 31.8.2023 | 31.8.2022 | |
|---|---|---|---|---|
| Turnover | 338 t€ | 297 t€ | 297 t€ | 301 t€ |
| Other operating income | 19 t€ | 20 t€ | 14 t€ | 38 t€ |
| Raw materials and services | 37 t€ | -40 t€ | -37 t€ | -26 t€ |
| Personnel expenses | 144 t€ | -56 t€ | -50 t€ | -68 t€ |
| Depreciations and reductions in value | 317 € | -423 € | -564 € | -752 € |
| Other operating expenses | 127 t€ | -118 t€ | -99 t€ | -97 t€ |
| Operating profit (loss) | 50 t€ | 103 t€ | 125 t€ | 148 t€ |
| Financial income and expenses + (-) | -4 752 € | 4 334 € | 590 € | -6 413 € |
| Profit (loss) before appropriations and taxes | 54 t€ | 107 t€ | 125 t€ | 141 t€ |
| Income taxes | 11 t€ | -22 t€ | -26 t€ | -32 t€ |
| Profit (loss) for the financial year | 43 t€ | 85 t€ | 99 t€ | 109 t€ |
| Non-current assets | 448 t€ | 448 t€ | 584 t€ | 572 t€ |
| Receivables | 85 t€ | 69 t€ | 33 t€ | 39 t€ |
| Cash in hand and at banks | 133 t€ | 128 t€ | 78 t€ | 159 t€ |
| Current assets | 612 t€ | 575 t€ | 447 t€ | 435 t€ |
| Assets | 1,1 M€ | 1,0 M€ | 1,0 M€ | 1,0 M€ |
| Share capital or other similar capital | 2 523 € | 2 523 € | 2 523 € | 2 523 € |
| Capital and reserves | 921 t€ | 954 t€ | 945 t€ | 919 t€ |
| Long-term liabilities | 30 t€ | 40 t€ | 49 t€ | 59 t€ |
| Short-term liabilities | 109 t€ | 29 t€ | 38 t€ | 29 t€ |
| Liabilities | 140 t€ | 69 t€ | 87 t€ | 88 t€ |
| Long-term liabilities to credit institutions | 28 t€ | 37 t€ | 46 t€ | 55 t€ |
| Other current liabilities | 82 t€ | 7 474 € | 4 595 € | 12 t€ |
| Wages and salaries | 116 t€ | -38 t€ | -34 t€ | -49 t€ |
| Other receivables (investments) | – | – | 0 € | 8 575 € |
| Pension expenses | 20 t€ | -15 t€ | -14 t€ | -17 t€ |
| Tangible assets | 11 t€ | 11 t€ | 12 t€ | 3 655 € |
| Reductions in value of shares and holdings in current assets | -514 € | -1 899 € | -3 259 € | -17 t€ |
| Depreciations according to plan | 317 € | -423 € | -564 € | -752 € |
| Liabilities | 1,1 M€ | 1,0 M€ | 1,0 M€ | 1,0 M€ |
| Other short-term receivables | 111 € | 985 € | 2 293 € | 3 169 € |
| Investments | 437 t€ | 437 t€ | 573 t€ | 568 t€ |
| Other social security expenses | 7 695 € | -3 692 € | -1 885 € | -1 534 € |
| Profit (loss) for the period, equity | 43 t€ | 85 t€ | 99 t€ | 109 t€ |
| Other long-term liabilities | 2 575 € | 3 130 € | 3 659 € | 4 223 € |
| Other shares and holdings | 395 t€ | 379 t€ | 336 t€ | 238 t€ |
| Services purchased | 19 t€ | -28 t€ | -20 t€ | -17 t€ |
| Retained earnings | 875 t€ | 866 t€ | 843 t€ | 807 t€ |
| Short-term liabilities to credit institutions | 8 940 € | 8 940 € | 8 940 € | 8 940 € |
| Purchases during the financial year | 18 t€ | -12 t€ | -17 t€ | -8 912 € |
| Other tangible assets | 9 975 € | 9 975 € | 9 975 € | 1 400 € |
| Short-term prepayments and accrued income | 23 t€ | 42 t€ | 19 t€ | 29 t€ |
| Other interest and financial income from non-group companies | 14 t€ | 9 026 € | 8 226 € | 23 t€ |
| Other shares and similar rights of ownership | 437 t€ | 437 t€ | 573 t€ | 560 t€ |
| Short-term accrued expenses and deferred income | 9 274 € | 5 443 € | 7 109 € | 6 592 € |
| Shares and holdings | 395 t€ | 379 t€ | 336 t€ | 238 t€ |
| Short-term sales receivables | 9 532 € | 26 t€ | 12 t€ | 6 320 € |
| Short-term receivables | 85 t€ | 69 t€ | 33 t€ | 39 t€ |
| Short-term loan receivables | 52 t€ | 0 € | – | – |
| Interest expenses and other financial expenses for non-Group companies | 9 682 € | -2 793 € | -4 378 € | -13 t€ |
| Machinery and equipment | 951 € | 1 268 € | 1 691 € | 2 255 € |
| Short-term accounts payable | 9 544 € | 7 455 € | 17 t€ | 1 827 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Medicine Man Oy is in the top quarter of the industry class programme agencies and management service activities for culture (289 companies with taxable income; median 13 t€, 8,3 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.
Sales to public buyers
Largest buyers
Free monthly list: Helsinki
Once a month by email: new leads in this municipality and its neighbours, the month's figures and the full list. No charge, no commitment, cancel any time.
Follow companies in your area
New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.
Try for free